Back to all news

AI Model Predicts Microsatellite Instability and Immunotherapy Response from Histology

EurekAlertResearch
AI Model Predicts Microsatellite Instability and Immunotherapy Response from Histology

Yonsei University researchers introduced MSI-SEER, an AI model for MSI and immunotherapy response prediction from histology images of gastric and colorectal cancers.

Key Details

  • 1MSI-SEER uses deep Gaussian process modeling to analyze H&E-stained whole-slide images.
  • 2The model integrates uncertainty quantification, providing a Bayesian Confidence Score for each prediction.
  • 3MSI-SEER flags uncertain cases for human review to enhance reliability and safety.
  • 4Validated on large, racially diverse datasets, it achieved state-of-the-art MSI prediction accuracy.
  • 5The model also predicts immune checkpoint inhibitor (ICI) response, integrating tumor MSI status and stroma-to-tumor ratio.
  • 6Published in npj Digital Medicine on May 19, 2025.

Why It Matters

This innovation demonstrates the power of AI in pathology to provide clinically actionable predictions and to integrate uncertainty for safer AI-human collaboration in cancer diagnosis and therapy selection. The approach may serve as a model for broader use of AI in precision oncology workflows.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.